Jazz Pharmaceuticals plc 4

Insider Patrick G. Enright disposed of a total of 1,706 Jazz Pharmaceuticals plc ordinary shares on August 31, 2026 in tax-related transactions connected to RSU vesting.

On August 31, 2026, Patrick G. Enright, a reporting insider of Jazz Pharmaceuticals plc, had ordinary shares withheld and disposed of to cover tax obligations arising from the vesting of previously granted restricted stock units. The Form 4 reflects two tax-related disposition entries coded as transaction type “F”: 14 ordinary shares at an average price of approximately $244.64 per share and 1,692 ordinary shares at an average price of approximately $241.39 per share, implying an aggregate tax-related sale value of roughly $410,000. Following these transactions, Enright’s directly held ordinary share ownership stood at 22,970 shares after the first entry and 21,278 shares after the second entry. These transactions appear to be routine, compensation-related tax withholdings rather than discretionary open-market sales.

Filing Facts

CIK

1232524

Ticker

JAZZ

Form

4

Source Type

fda

Accession

0001253886-26-000011

Alert Tier

5